SMAD2 and hepatocellular carcinoma: Collectively, HA-ADT inhibited HCC via promoting apoptosis through suppressing GSK-3β/AKT/β-catenin and inhibiting autophagy through suppressing TGF-β/Smad2/3 pathways (Duan et al., 2023).